Management of postoperative atrial fibrillation

Journal of Cardiovascular Nursing

Volumn 12, Issue 3, 1998, Pages 57-77

  Kern, Leslie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CORONARY ARTERY BYPASS GRAFT; HEART ATRIUM FIBRILLATION; HUMAN; NURSING; POSTOPERATIVE COMPLICATION; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 0032036444     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-199804000-00008     Document Type: Article

References (98)

1. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996; 335(25):1857-1863.
2. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery. JAMA. 1996;276(4):300-306.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993; 56: 539-549.
4. Waldo AL, Henthorn RW, Epstein AE, Plumb VJ. Diagnosis and treatment of arrhythmias during and following open heart surgery. Med Clin NAm. 1984;68(5): 1153-1169.
5. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting: Is it a disorder of the elderly? J Thorac Cardiovasc Surg. 1989;97(6):821-825.
6. Crosby LH, Pifalo WB, Woll KR, Burkholder JA. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 1996;66:1520-1522.
7. Nally BR, Dunbar SB, Zellinger M, Davis A Supraventricular tachycardia after coronary artery bypass grafting surgery and fluid and electrolyte variables. Heart Lung. 1996;25(1):31-36.
8. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;100(3):338-342.
9. Douglas P., Hirshfeld JW, Edmunds H. Clinical correlates of postoperative atrial fibrillation. Circulation. 1984;70(suppl II):11-165. Abstract.
10. Mantangi MF, Neutze JM, Graham KJ, et al. Arrhythmia prophylaxis after aorta-coronary bypass: The effect of minidose propranolol. J Thorac Cardiovasc Surg. 1985;89(3): 439-443.
11. Michaelson EL, Morganroth J, MacVaugh H. Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring. Am Heart J. 1979;97(4):442-448.
12. Pavri BB, O’Nunain SS, Newell JB, Ruwskin JN, Dec GW. Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol. 1995;25(7):1673-1680.
13. Chung MK, Asher CR, Dykstra D, et al. Atrial fibrillation increases length of stay and cost after cardiac surgery in low risk patients targeted for early discharge. J Am Coll Cardiol. 1996;28:309A. Abstract.
14. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol. 1992;69:963-965.
15. Vecht RJ, Nicolaides EP, Ikweuke JK, et al. Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. Intf Cardiol. 1986;13:125-134.
16. Bush HL, Gelband H, Hoffman BF, Malm JR. Electrophysiologicalbasis for supraventricular arrhythmias following surgical procedures for aortic stenosis. Arch Surg. 1971;103:620-625.
17. Buxton AE, Josephson ME. The role of p wave duration as a predictor of postoperative atrial arrhythmias. Chest. 1981;80(1): 68-73.
18. Capucci A, Frabetti L, Turinetto B, Pierangeli A, Magnani B. Fibrillazione atriale nei post operati de by-pass aortocoronarica. G Ital Cardiol. 1987;17:575-582.
19. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg. 1993;56:405-409.
20. Oshima H, Usui A, Murakami F, et al. Value of the regional P-wave recorded by signalaveraged EKG on the atrium for predicting atrial fibrillation after cardiac surgery. Circulation. 1996(suppl I):1-69. Abstract.
21. Steinberg JS, Zelenkofske DO, Wong SC. Value of the P-wave signal averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;6:2618-2622.
22. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg. 1991;101:56-65.
23. Franz MR. Monophasic action potential recording. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: WB Saunders; 1995:1170-1178.
24. Levine JH, Guarnieri T, Kadish AH. Changes in myocardial repolarization in patients undergoing balloon valvuloplasty for congenital pulmonary stenosis: Evidence for contraction-excitation feedback in humans. Circulation. 1988;77:70-77.
25. Asher CR, Dykstra D, Miller DP, et al. Advanced age and left atrial enlargement predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. J Am Coll Cardiol. 1996; 27(suppl A): 310A.
26. Klein M, Evans SJ, Blumberg S, Cataldo L, Bodenheimer MM. Use of P-wave triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1995; 129(5):895-901.
27. Sideris DA, Toumanidis ST, Thodorakis M, et al. Some observations on the mechanism of pressure related atrial fibrillation. Eur Heart J. 1994;15:1585-1589.
28. Olshansky B, Kleinman B, Wilber D. Management of arrhythmias and conduction disturbances in the perioperative setting. In: Naccarelli GV, ed. Clinical Cardiovascular Therapeutics: Vol. 2 Cardiac Arrhythmias: A Practical Approach. Mt. Kisco, NY: Futura Publishing; 1991:325-358.
29. Spodick DH. Arrhythmias during acute pericarditis. JAMA. 1976; 235(1):39-41.
30. Stevenson LW, Child JS, Laks H, Kern L. Incidence and significance of early pericardial effusions after cardiac surgery. Am J Cardiol. 1984;54:848-851.
31. Dixon FE, Genton E, Vacek JL, Moore CB, Landry J. Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting. Am J Cardiol. 1985; 58:476-478.
32. Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. ¡Thorac Cardiovasc Surg. 1987;94(3):331-335.
33. Boyden PA, Hoffman BF. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs. CircRes. 1981;49(6):1319-1331.
34. Laub GW, Janeira L, Muralidharan S, et al. Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: aprospective, double-blind, randomized, placebo-controlledpilotstudy. Crit Care Med. 1993;21(10):1474-1478.
35. Gold MR, O’Gara PT, Buckley MJ, DeSanctis RW. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol. 1996; 78:975-979.
36. Rose MR, Glassman E, Spencer FC. Arrhythmias following cardiac surgery: Relation to serum digoxin levels. Am Heart J. 1975;89(3):288-294.
37. Fanning WJ, Thomas CS, Roach A, Tomichek R, Alford WC, Stoney WS. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg. 1991;52:529-533.
38. Ganz LI, Tanasijevic MJ, Couper G, et al. Effect of cardiopulmonary bypass on plasma ionized magnesium level and correlation with atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol. 1996:309A.
39. Katholi RE, Taylor GJ, Woods WT, et al. MgC12 replacement after bypass surgery to prevent atrial fibrillation: A double blind, randomized trial. Circulation. 1990; 82(suppl III):3-58. Abstract.
40. Berger AK, Trivedi KK, Katz NM, et al. Does adjunctive magnesium prevent atrial fibrillation following coronary artery bypass surgery? Circulation. 1996;94(suppl I):1-170. Abstract.
41. Chernow B. Essentials of Critical Care Pharmacology. Baltimore, MD: Williams & Wilkins; 1989.
42. Lauer MS, Eagle KA. Atrial fibrillation following cardiac surgery. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. New York: Raven Press; 1992:127-143.
43. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized controlled trials. Circulation. 1991;84(suppl III):III-236 III-244.
44. Santoli E, DiMattia DG, Scröfani R. Atrial fibrillation and flutter after open heart operation. Ann Thorac Surg. 1992;53:940-945.
45. Mills SA, Poole GV, Breyer RH, et al. Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting. Circulation. 1983;68(suppl II):11-222-11-225.
46. Omerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC. Arrhythmias after coronary bypass surgery. Br Heart J. 1984;51:618-621.
47. Davison R, Hartz R, Kaplan K, Parter M, Feiereisel P, Michaelis L. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: Arandomized, double-blind trial. Ann Thorac Surg. 1985;39(4):336-339.
48. Matloff JM, Wolfson S, Gorlin R, et al. Control of post-cardiac surgical tachycardias with propranolol. Circulation. 1968; 37(suppl II):133. Abstract.
49. Salazar C, Frishman W, Friedman S. Betablockade therapy for supraventricular tachyarrhythmias after coronary surgery: A propranolol withdrawal syndrome? Angiology. 1979;30(12):816-819.
50. Stephenson LW, MacVaugh H, Tomasello DN, Josephson ME. Propranolol for prevention of postoperative cardiac arrhythmias: A randomized study. Ann Thorac Surg. 1980;29(2):113-116.
51. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: A prospective, randomized study. Ann Surg. 1982;196(2):194-197.
52. Abel RM, van Gelder HM, Pores IH, et al. Continued propranolol administration following coronary bypass surgery. Arch Surg. 1983;118:727-731.
53. Mohr R, Smolinsky A, Goor DA. Prevention of supraventricular tachyarrhythmia with low-dose propranolol after coronary bypass. J Thorac Cardiovasc Surg, 1981; 81(6):840-845.
54. Williams JB, Stephenson LW, Holford FD, Langer T, Dunkman WB, Josephson ME. Arrhythmia prophylaxis using propranolol after coronary artery surgery. Ann Thorac Surg. 1982;34(4):435-438.
55. Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel EA, Miller DW. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization: A randomized trial. J Thorac Cardiovasc Surg. 1983;85(2):214-218.
56. White HD, Antman EM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation. 1984;70(3):479-484.
57. Hammon JW, Wood AJJ, Prager RL, Wood M, Muirhead J, Bender HW. Perioperative betablockade with propranolol: Reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Ann Thorac Surg. 1984;38(4):363-367.
58. Daudon P, Corcos T, Gandjbakhch I, Levasseur JP, Cabrol A, Cabrol C. Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. Am J Cardiol. 1986;58:933-936.
59. Yousif H, Davies G, Oakley CM. Peri-operative supraventricular arrhythmias in coronary bypass surgery. IntJCardiol. 1990; 26:313-318.
60. Suttorp MJ, Kingma JH, Peels HOJ, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol. 1991;68:1163-1169.
61. Podesser BK, Schwarzacher S, Zwoelfer W, Binder TM, Wolner E, Seitelberger R. Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1995;110(5):1461-1469.
62. Graham SP, Hasnain S, Celano J. Low dose but not medium dose beta blockers reduce postoperative atrial fibrillation. Circulation. 1996;94(suppl I):1-190. Abstract.
63. Weber UK, Pfisterer M, Osswald S, Huber M, Buser P, Stulz P. Low dose sotalol to prevent supraventricular arrhythmias after CABG surgery and its effects on hospital stay. J Am Coll Cardiol. 1996;28:309A. Abstract.
64. Hondeghem LM. Class III agents: Amiodarone, bretylium, and sotalol. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology. 2nd ed. Philadelphia, PA: WB Saunders; 1995.
65. Doerge HC, Schoendube FA, Vog M, et al. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with intravenous amiodarone. Circulation. 1996;94(suppl I):1-190. Abstract.
66. Redle JD. Prophylactic low dose amiodarone versus placebo to prevent atrial fibrillation in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 1997;29(2, suppl A):289A.
67. Chung MK, Augostini RS, Asher CR. A randomized, controlled study of atrial overdrive pacing for the prevention of atrial fibrillation after coronary artery bypass surgery. Circulation. 1996;94(suppl I):1-190. Abstract.
68. Mittleman RS, Hill MR, Mehra R, et al. Evaluation of the effectiveness of right atrial and biatrial pacing for the prevention of atrial fibrillation (AF) after coronary artery bypass surgery (CABG). Circulation. 1996; 94(suppl I):1-68. Abstract.
69. Sopher SM, Camm AJ. Atrial fibrillation: Maintenance of sinus rhythm versus rate control. Am J Cardiol 1996;77(3):24A-37A.
70. Deutch N, Naccarelli GV. Dysrhythmias following open heart surgery. In: Williams, JP, ed. Postoperative Management of the Cardiac Surgery Patient. New York: Churchill Livingston; 1996:243-256.
71. Nattel S. Newer developments in the management of atrial fibrillation. Am Heart J 1995;130(5):1094-1106.
72. Olshansky B. Management of atrial fibrillation after coronary artery bypass graft. Am J Cardiol. 1996;78(suppl 8A):27-34.
73. Tisdale JE, Padhi ID, Goldberg AD, et al. Diltiazem controls ventricular rate more rapidly but not more effectively than digoxin in patients with atrial fibrillation following coronary artery bypass surgery. Circulation. 1996;94(suppl I): 1-190. Abstract.
74. Gray RJ. Diagnosis and management of arrhythmias in post-cardiac surgical patients. In: Mandel WJ, ed. Cardiac Arrhythmias. Philadelphia, PA: JB Lippincott; 1995:1019-1033.
75. Chronister C. Clinical management of supraventricular tachycardia with adenosine. Am J Coll Cardiol. 1993;2(1):41-47.
76. Philichi LM, Bryerton M, Bates J. A pediatric case study: Use of adenosine in the treatment of supraventricular tachycardia. Am J Coll Cardiol. 1994;3(3):228-231.
77. Singh BN. Beta-blockers and calcium channel blockers as antiarrhythmic drugs. In Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: WB Saunders; 1995:1317-1329.
78. Schwartz M, Mickelson EL, Sawin HS, Mac-Vaugh H. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Chest. 1988;93(4):705-711.
79. Kumar A. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J. 1996;89(8):779-785.
80. DiMarco, JP. Antiarrhythmics. In: Chernow B. Essentials of Critical Care Pharmacology. Baltimore, MD: Williams & Wilkins; 1989:168-206.
81. Ellenbogen KA. Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol. 1996;28(1):130-136.
82. Moore SL, Wilkoff BL. Rhythm disturbances after cardiac surgery. Sem Thorac Cardiovasc Surg. 1991;3(1):24-28.
83. Kishore AG, Camm AJ. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Drugs. 1995;50(2): 250-262.
84. Dunnington CS. Sotalol hydrochloride (Betapace): A new antiarrhythmic drug. Am J Coll Cardiol. 1993;2(5):397-406.
85. Jaquet L, Evenepoel M, Marenne F, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac VascAnesth. 1994; 8(4):431-436.
86. Conover MB. Understanding Electrocardiography. St. Louis, MO: Mosby; 1996.
87. Vlay SC. A Practical Approach to Cardiac Arrhythmias. Boston, MA: Little, Brown; 1996.
88. Gentil C, Giordano F, Alois A, Massa E, Bianconi L. Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery. Am Heart J. 1992;123(5):1225-1228.
89. Reiffel JA, Haffajee CI. Atrial fibrillation update 1996: Case II. Cardiovasc Rev Rep. 1996;17(7):36-60.
90. Luderitz B, Pfeiffer D, Tebbenjohanns J, Jung W. Nonpharmacologic strategies for treating atrial fibrillation. Am J Cardiol. 1996;77(3):45A-52A.
91. Carlsson J, Tebbe U, Rox J, et al. Cardioversion of atrial fibrillation in the elderly. Am J Cardiol. 1996;78(12):1380-1384.
92. Pagan-Carlo LA, Seabury-Stone M, Kerber RE. Nature and determinants of skin burns after transthoracic cardioversion. Am J Cardiol. 1997;79:689-692.
93. Kerber RE. Transthoracic cardioversion of atrial fibrillation and flutter: Standard techniques and new advances. Am J Cardiol. 1996;78(suppl 8A):22-26.
94. Ortiz J, Sokoloski MC, Ayers GM, et al. Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes: Studies in the canine sterile pericarditis model. J Am Coll Cardiol. 1995; 26(5):1356-1364.
95. Ammer R, Alt E, Ayers G, et al. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. PACE. 1997;20:230-236.
96. Slade AKB, Murgatroyd FD, Ricard P, Levy S, Camm JA. Pacemakers and implantable defibrillators in atrial fibrillation. In: Atrial Fibrillation: Mechanisms and Management. Philadelphia: Lippincott/Raven; 1997:439-463.
97. Page PL, Pym J. Atrial fibrillation following cardiac surgery. Can J Cardiol. 1996; 12(suppl A):40A-44A.
98. Chauhan VS, Gill I, Woodend KA, Tang AS. Lower incidence of atrial fibrillation after minimally invasive direct coronary artery bypass surgery (MIDCAB) than bypass surgery (CABG). Circulation. 1997; (suppl 1): 1-263. Abstract.